Watchlist
FA · First Advantage Corporation
Last analysed ·
Against its published line
1 name has closed through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 18 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-08-21 at medium conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first time. A second leg on a labour-cyclical base that is still decelerating; the next test is payrolls, not the company.
Kill line
A weekly close below $22 returns price inside the pre-print July range ($19.91–$22.49) and negates the Aug 6 earnings breakout; base revenue growth printing under 6.7% or a trimmed FY revenue range at the Q3 report would confirm the labour-cycle drag reaching the volume base.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for FA —
As of 13 September 2026, the latest FrontierPicks analysis for First Advantage Corporation (FA): Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first time. A second leg on a labour-cyclical base that is still decelerating; the next test is payrolls, not the company.
Kill line: A weekly close below $22 returns price inside the pre-print July range ($19.91–$22.49) and negates the Aug 6 earnings breakout; base revenue growth printing under 6.7% or a trimmed FY revenue range at the Q3 report would confirm the labour-cycle drag reaching the volume base.
Most recent dated event on file: — catalyst 5d ago.
Current Thesis
First Advantage’s raised revenue outlook supports a tentative range-recovery thesis, settled by a weekly close above July’s $22.49 ceiling before a weekly close below its $19.91 floor. This is a narrower case than the August earnings breakout: that thesis already failed at the published $22 threshold, with weekly closes of $20.90 on 2026-08-21 and $21.04 on 2026-08-28. The adjusted reference close of $21.22 on 2026-09-11 remains inside that July range.
The operating argument remains the post-Sterling business’s growth: First Advantage reported second-quarter revenue of $448.8 million, up 14.9% year over year, and raised full-year revenue guidance to $1.67–1.71 billion on 2026-08-06. The narrative is maturing — the earnings improvement is published, management’s calendar lists conference appearances on 2026-09-09 and 2026-09-10, and the subsequent reference close remains below the old breakout threshold. That classification is an inference from the dated results, calendar and price structure; a weekly recovery above $22.49 would overturn the present assessment of failed price confirmation. Quarterly results, company event calendar.
Bullish and bearish views on First Advantage Corporation
The model's bull view on First Advantage Corporation (FA), in brief: The revenue outlook was raised. The 2026-08-06 results increased full-year 2026 revenue guidance to $1.67–1.71 billion and adjusted diluted earnings per share guidance to $1.23–1.29. These are management forecasts; a subsequent reduction would contradict the operating recovery… The bear view: Price confirmation remains absent. The 2026-09-11 adjusted close of $21.22 is below both the previously invalidated $22 breakout threshold and July’s $22.49 range ceiling. The positive three-month price change of 28.7% supplied for that date does not establish that the failed… Both cases follow in full.
Bull Case
- The revenue outlook was raised. The 2026-08-06 results increased full-year 2026 revenue guidance to $1.67–1.71 billion and adjusted diluted earnings per share guidance to $1.23–1.29. These are management forecasts; a subsequent reduction would contradict the operating recovery case. Results release.
- Existing customers contributed growth. The 2026-08-06 earnings call reported second-quarter base-revenue growth of 6.7%, alongside 12.5% growth from upselling, cross-selling and new customers. Base-revenue growth below 6.7% at the next quarterly report would weaken the claim that existing screening demand supports the raised outlook.
- The latest payroll release improved. The Bureau of Labor Statistics reported on 2026-09-04 that August nonfarm employment increased by 162,000 jobs, with unemployment unchanged at 4.1%. This replaces the prior note’s expectation of another weakening monthly release, but one observation is too small a sample to establish a durable hiring recovery. August employment report.
Bear Case
- Price confirmation remains absent. The 2026-09-11 adjusted close of $21.22 is below both the previously invalidated $22 breakout threshold and July’s $22.49 range ceiling. The positive three-month price change of 28.7% supplied for that date does not establish that the failed breakout has repaired.
- its supplement describes a secondary offering of 12,500,000 shares at $22.20 per share. Registration permits sales but does not require them, so it cannot establish how much additional supply will reach the market. Offering prospectus.
- Debt qualifies the earnings improvement. First Advantage’s 2026-06-30 financial figures showed long-term debt of $2,033.8 million against cash of $237.9 million. The 2026-08-06 release also reported a voluntary debt prepayment of $45 million on 2026-08-04; these figures document both the debt burden and repayment activity, without establishing that deleveraging will continue. Quarterly results.
Setup & Price Structure
The market’s July 2026 range of $19.91–$22.49 supplies the boundaries for this distinct recovery case. The $19.91 floor is not a replacement for the old breakout’s failed $22 condition: the historical failure remains recorded. Success for the present case means a weekly close above $22.49 before a weekly close below $19.91.
The 2026-09-11 snapshot places the shares 12.0% below the supplied 52-week high of $24.12. No moving-average value, trading-volume series or retail-positioning measure accompanies that snapshot, so neither moving-average extension nor retail crowding is established. The observable supply event is the August secondary; the $21.22 reference close remains below its $22.20 public offering price, but that comparison does not identify the current marginal seller. Offering terms.
Catalyst Calendar (next 30 days)
- 2026-10-02 — September US employment report. The Bureau of Labor Statistics’ 2026-09-04 release specifies this next publication date. It supplies another hiring observation after August’s improvement, although company base-revenue growth remains the direct test of screening demand. Release schedule in the employment report.
The company event calendar reviewed on 2026-09-13 does not list a third-quarter earnings date. An estimated November date is therefore not presented as a confirmed catalyst. Company calendar.
Elapsed catalysts
- 2026-09-15 — Barclays Global Financial Services Conference. First Advantage’s 2026-09-02 announcement schedules management’s webcast and investor meetings for this date. The event provides an opportunity for commentary on screening demand and the raised outlook; the scheduled appearance itself supplies no new financial confirmation. Conference announcement. (passed 5d ago)
What Would Change Our Mind
Loss of July’s range floor would end the recovery case: a weekly close below $19.91 is the price invalidation. Conversely, a weekly close above July’s $22.49 ceiling before that breach would satisfy the defined price case. These conditions leave the already-failed August breakout separate from the current hypothesis.
The operating argument would also break if the next quarterly report cuts the $1.67–1.71 billion full-year revenue range issued on 2026-08-06. Base-revenue growth below that quarter’s 6.7% would provide a separate, observable sign of deterioration in existing-customer demand. The evidence supports low conviction because the raised outlook has yet to produce recovery through the documented July ceiling.
Correlation Notes
This is a single-name acquisition-integration and hiring-volume case. Sterling’s acquisition closed on 2024-10-31, while the 2026-08-06 call reported growth in both existing-customer activity and additional services; those are the company-specific operating channels under examination. No sector-return series establishes that a group rally explains FA’s 2026-09-11 price structure.
The 2026-09-04 employment report measures net payroll changes, whereas First Advantage’s second-quarter base-revenue measure describes customer activity. Treating payrolls as a directional demand input is an inference, not a measured stock-price correlation. The available observations are too few to quantify that relationship. Bureau of Labor Statistics report.
Notes
- Silver Lake affiliates have anchored the register since the 2020 take-private;
- Revenue is levered to US hiring volume rather than AI capex; the monthly BLS payroll release is the highest-frequency input to the base-revenue line.
- Long-term debt was $2,033.8M against $237.9M cash at 2026-06-30; the equity is a levered claim on screening volumes.
- FY2026 guidance is calendar-year and was raised 2026-08-06: revenue $1.67-1.71B, adj EBITDA $472-486M, adj diluted EPS $1.23-1.29.
- Sterling ($2.2B) closed 2024-10-31, so YoY comparisons from Q1 2026 onward are against a combined base rather than a deal-inflated one.
- No Q3 2026 reporting date had been announced as of 2026-08-30; the ~2026-11-05 reference is an estimate from prior-year timing.
Related · shared themes
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.
DSGR
Distribution Solutions Group, Inc.
Distribution Solutions Group’s $35.00 cash acquisition remains a completion thesis, with the minority vote and closing settling the case. HSR clearance occurred on 2026-08-20; a daily close below $33.50 invalidates the price thesis.
ATKR
Atkore Inc.
Atkore's $95.00 cash-merger thesis now turns on the October 7 shareholder vote and remaining approvals after September 14 US antitrust clearance. Completion before a weekly close below $88 constitutes success; termination negates the case.